[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
November 9, 2005

Resignation Inquiry

JAMA. 2005;294(18):2292. doi:10.1001/jama.294.18.2292-c

Some members of Congress are calling for an investigatation of the abrupt resignation of Lester M. Crawford, DVM, as commissioner of the Food and Drug Administration. Crawford resigned on September 23, serving only 2 months after his confirmation. He had been the acting head of the Food and Drug Administration since 2002.

In the week following Crawford’s resignation, some members of Congress asked the inspector general of the Department of Health and Human Services (HHS) to examine whether Crawford’s financial reporting had complied with various ethics laws. Newspaper accounts said Crawford had failed to reveal all of his financial information to the Senate prior to confirmation hearings earlier this year.

First Page Preview View Large
First page PDF preview
First page PDF preview